← Leaderboards
Lisa M Bebell
Massachusetts General Hospital
$4,084,300
Attributed
$4,084,300
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,084,300 · 4
By mechanism
R01$2,396,349 · 1
K23$1,069,623 · 1
R21$618,328 · 2
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Andrea Goldberg Edlow$11,000,739
- Boris Dominik Juelg$12,991,342
- Galit Alter$32,273,423
- Xinyuan Chen$4,097,118
- Mei X Wu$13,491,815
Others in their field
Other Emerging Leaders on “United States National Institutes Of Health”
- Leonard Freedman · Leidos Biomedical Research, Inc.$816,847,401
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$250,731,514
Research focus
United States National Institutes Of HealthChildEnrollmentCohortAntiretroviral TherapyResearch PersonnelUgandaInnovationChild HealthBirthPlacentaGrowthInfectionReportingPregnant WomenImproved OutcomeMorbidity - Disease RatePharmaceutical PreparationsImmuneImmunologyLinkInflammatoryMothersCaring
Grant awards (11)
Microbiome-driven immune changes and growth stunting in HIV-exposed uninfected children$792,899
R01 · FY2025 · HD · contact PI
Impact of in utero HIV and antiretroviral exposure on the placenta and birth weight$244,328
R21 · FY2025 · AI · contact PI
Microbiome-driven immune changes and growth stunting in HIV-exposed uninfected children$792,925
R01 · FY2024 · HD · contact PI
Microbiome-driven immune changes and growth stunting in HIV-exposed uninfected children$810,525
R01 · FY2023 · HD · contact PI
HIV Infection, Placental Inflammation, and Early Childhood Outcomes in HIV-exposed, Uninfected Infants in Uganda$271,941
K23 · FY2023 · AI · contact PI
HIV Infection, Placental Inflammation, and Early Childhood Outcomes in HIV-exposed, Uninfected Infants in Uganda$199,800
K23 · FY2022 · AI · contact PI
Effects of HIV, antiretroviral therapy, and PrEP on placental structure and metabolic function$165,000
R21 · FY2022 · AI · contact PI
Effects of HIV, antiretroviral therapy, and PrEP on placental structure and metabolic function$209,000
R21 · FY2021 · AI · contact PI
HIV Infection, Placental Inflammation, and Early Childhood Outcomes in HIV-exposed, Uninfected Infants in Uganda$198,041
K23 · FY2021 · AI · contact PI
HIV Infection, Placental Inflammation, and Early Childhood Outcomes in HIV-exposed, Uninfected Infants in Uganda$198,543
K23 · FY2020 · AI · contact PI
HIV Infection, Placental Inflammation, and Early Childhood Outcomes in HIV-exposed, Uninfected Infants in Uganda$201,298
K23 · FY2019 · AI · contact PI